Skip to main content

Juliet Gallagher

News
01/15/2025
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has...
01/15/2025
Pharmacy Learning Network
News
01/15/2025
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a...
01/15/2025
Pharmacy Learning Network
News
01/13/2025
A recent study published in Journal of Managed Care & Specialty Pharmacy explored multiple sclerosis (MS) as a compelling therapeutic area for outcomes-based agreements (OBAs) by assessing the use of patient-reported disability progression to...
A recent study published in Journal of Managed Care & Specialty Pharmacy explored multiple sclerosis (MS) as a compelling therapeutic area for outcomes-based agreements (OBAs) by assessing the use of patient-reported disability progression to...
A recent study published in...
01/13/2025
First Report Managed Care
News
01/10/2025
Venture capital investment in health care experienced a resurgence in 2024, fueled by enthusiasm for artificial intelligence (AI) startups, according to a report by Silicon Valley Bank (SVB).
Venture capital investment in health care experienced a resurgence in 2024, fueled by enthusiasm for artificial intelligence (AI) startups, according to a report by Silicon Valley Bank (SVB).
Venture capital investment in...
01/10/2025
Integrated Healthcare Executive
News
01/09/2025
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI...
01/09/2025
Journal of Clinical Pathways
News
01/03/2025
The Department of Health and Human Services (HHS) and the Office for Civil Rights (OCR) proposed significant updates to the HIPAA Security Rule to address evolving cybersecurity threats, modernize protections for electronic protected health...
The Department of Health and Human Services (HHS) and the Office for Civil Rights (OCR) proposed significant updates to the HIPAA Security Rule to address evolving cybersecurity threats, modernize protections for electronic protected health...
The Department of Health and...
01/03/2025
Integrated Healthcare Executive
News
12/20/2024
Despite advancements in understanding the molecular basis of myelofibrosis (MF), a rare and complex bone marrow disorder, predicting disease outcomes and tailoring treatments remains challenging. A study published in Cancers used real-world...
Despite advancements in understanding the molecular basis of myelofibrosis (MF), a rare and complex bone marrow disorder, predicting disease outcomes and tailoring treatments remains challenging. A study published in Cancers used real-world...
Despite advancements in...
12/20/2024
Journal of Clinical Pathways
News
12/19/2024
A study published in Journal of Managed Care and Specialty Pharmacy evaluated the budgetary implications of introducing etranacogene dezaparvovec, a novel gene therapy for hemophilia B, into a US commercial health plan.
A study published in Journal of Managed Care and Specialty Pharmacy evaluated the budgetary implications of introducing etranacogene dezaparvovec, a novel gene therapy for hemophilia B, into a US commercial health plan.
A study published in Journal of...
12/19/2024
First Report Managed Care
News
12/19/2024
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health...
12/19/2024
First Report Managed Care